Should blood be an essential medicine?

New England Journal of Medicine

Volumn 368, Issue 3, 2013, Pages 199-201

  Klein, Harvey G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; IMMUNOGLOBULIN;

AWARENESS; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; ERYTHROCYTE TRANSFUSION; HEALTH CARE NEED; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PATIENT SAFETY; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; QUALITY CONTROL; SHORT SURVEY;

EID: 84872448701     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1213134     Document Type: Article

References (5)

1. The selection and use of essential medicines. Geneva: World Health Organization, 2003 (http://apps.who.int/medicinedocs/en/d/Js4875e/5.2.html).
2. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007;370:415-26.
3. Akech SO, Hassall O, Pamba A, et al. Survival and haematological recovery of children with severe malaria transfused in accordance to WHO guidelines in Kilifi, Kenya. Malar J 2008;7:256-64.
4. Guide to the preparation, use and quality assurance of blood components. 16th ed. Strasbourg, France: European Directorate for the Quality of Medicines and HealthCare, 2010.
5. AABB standards for blood banks and transfusion services. 28th ed. Bethesda, MD: AABB, 2012.